A network of specialists, for better health

ABD Pharma Pars was established in 2024 with a mission to develop and manufacture recombinant biopharmaceuticals—including Interferons (Alpha, Beta, Gamma), Human Growth Hormone (hGH) and Parathyroid Hormone (PTH)—through fully domestic production. In line with advancing biotechnology and reducing dependency on imports, the company is focused on localizing production processes and enhancing the quality of biological medicines. With a specialized team and a strong R&D-driven approach, ABD Pharma Pars is committed to ensuring the sustainable supply of high-quality recombinant drugs in Iran.